So we know that Psivida has something brewing with Pfiser that was pretty clear. The last post about
Neuron Systems is that we have Johnson and Johnson looking over the shoulder at what Psivida is working on. I remember when that article came out. Came and went and the magnitude of the release was never really there. The fact of the matter is that Johnson and Johnson is funding Neuron Systems along with Dom. Assoc. So Mick you have said a number of times that the Good Dr. is conservative about what is released, I agree.
About Neuron Systems Back in 2008
Burlington-based biotech company Neuron Systems Inc. has raised $8.96 million in Series A funding, according to online reports.
Investors in Neuron Systems include Domain Associates LLC and Johnson & Johnson Development Corp., both based in New Jersey.
Neuron Systems is working on treating retinal diseases, reports state. The company was founded in 2005 from Thomas A. Jordan and Harvard University researcher John Dowling, The pair have filed a patent application with the U.S. Patent & Trademark office for compounds and methods to both treat and prevent age-related macular degeneration.